KNEU HEALTH LIMITED - Profile & Financials

Accounts Submitted 17 Apr 2025

Confirmation Statement Submitted

Net assets £1.81M £248.25K 2024 year on year

Total assets £1.99M £325.65K 2024 year on year

Total Liabilities £173.83K £77.39K 2024 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Blackwell House Guildhall Yard London Greater London EC2V 5AE

Office ()

Oxford, Oxfordshire, United Kingdom, Europe

Office (London)

10 Fitzroy Square, London, W1T 5HP

Office (London)

6th Floor, 2 Kingdom Street, Paddington, London W2 6BD

Website

neu.health

Credit Report

Discover KNEU HEALTH LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

£1.59M

Decreased by £11.78k (-1%)

Net Assets

£1.81M

Increased by £248.25k (+16%)

Total Liabilities

£173.83k

Increased by £77.39k (+80%)

Turnover

N/A

Employees

Increased by 2 (+22%)

Debt Ratio

Increased by 3 (+50%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

6 Allotments 2,546,700 Shares £2250004.40m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
24 Sept 2025	SEED-3 PREFERRED	891,960	£4.18m	£4.686
21 Oct 2024	SEED-2 PREFERRED	354,740	£4.398	£4.398
11 Jan 2023	ORDINARY	99,000	£98k	£0.99
11 Jan 2023	SEED PREFERRED	750,000	£2250000.00m	£3.00m
11 Jan 2023	ORDINARY	109,000	£119k	£1.09

Officers

6 active 2 resigned

Show resigned officers

						Status
Caroline Ann Cake	Director	British	England	52	18 Nov 2022	Active
Joel Schoppig	Director	Swiss	United Kingdom	40	14 Mar 2024	Active
John Glaser	Director	American	United States	70	16 Oct 2023	Active
Kinan Muhammed	Director	British	England	41	18 Nov 2022	Active
Nirdesh Kumar Gupta	Director	Indian	United States	47	18 Sept 2025	Active
Sean Slovenski	Director	American	United States	58	16 Oct 2023	Active

Shareholders

Shareholders (12)


The Chancellor, Masters And Scholars Of The University Of Oxford	5.2%	109,000	Ordinary	2 Jan 2025
Simon Arkell	1.2%	24,791	Deferred	2 Jan 2025
Simon Arkell	0.5%	10,209	Ordinary	2 Jan 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Oxford Science Enterprises Plc

United Kingdom

Active

Notified 11 Jan 2023

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent

Kinan Muhammed

Ceased 13 Dec 2022

Ceased

Caroline Ann Cake

Ceased 11 Jan 2023

Ceased

See All Controllers

Group Structure

OXFORD SCIENCE ENTERPRISES PLC united kingdom

KNEU HEALTH LIMITED Current Company

NEUHEALTH DIGITAL LTD united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
10 Oct 2025	Capital	Allotment of shares (GBP 29.967) on 2025-10-10	View(4 pages)
29 Sept 2025	Resolution	Resolutions	View(2 pages)
29 Sept 2025	Incorporation	Memorandum Articles	View(51 pages)
24 Sept 2025	Officers	Appointment of Mr Nirdesh Kumar Gupta as director on 2025-09-18	View(2 pages)
7 Jul 2025	Officers	Termination of David George Howells as director on 2025-07-07	View(1 page)